Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
| Autor: | Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2019 Jan; Vol. 17 (1), pp. 64-84. |
| DOI: | 10.6004/jnccn.2019.0001 |
| Abstrakt: | Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine screening, and treatment of precancerous lesions. However, due to inadequate screening protocols in many regions of the world, cervical cancer remains the fourth-most common cancer in women globally. The complete NCCN Guidelines for Cervical Cancer provide recommendations for the diagnosis, evaluation, and treatment of cervical cancer. This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations. For recommendations regarding treatment of recurrent or metastatic disease, please see the full guidelines on NCCN.org. (Copyright © 2019 by the National Comprehensive Cancer Network.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|